* Login for a full stack data experience
*Engagement stats are ongoing and dynamic
Allergan PLC; Bayer AG; Epipharm AG; Galderma SA; Obagi Cosmeceuticals LLC (Obagi Medical); Pierre Fabre SA; RXi Pharmaceuticals Corporation; SkinCeuticals; Vivier Pharma, Inc.
» Disease Indication (Vitiligo, Albinism, Other Disease Indications) » End-Use (Hospitals, Aesthetic Clinics, Dermatology Centers) » Treatment (Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion, Other Treatments)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
TABLE OF CONTENTS
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com